Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-MS recurrent demyelinating diseases.

Vesna V Brinar1

  • 1Department of Neurology, Faculty of Medicine, Neurology Service, REBRO Hospital Centre, Kispaticeva 12, 10.000 Zagreb, Croatia. vesna.brinar@zg.htnet.hr

Clinical Neurology and Neurosurgery
|June 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.

Neurology·2016
Same author

Should MS be treated by escalation or induction therapy?

Collegium antropologicum·2014
Same author

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

Lancet (London, England)·2012
Same author

Multiple brain cysts: an unusual form of radiologically isolated syndrome.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2012
Same author

Early-onset ataxia with progressive external ophthalmoplegia associated with POLG mutation: autosomal recessive mitochondrial ataxic syndrome or SANDO?

The neurologist·2012
Same author

Treatment of facial myokymia in multiple sclerosis with botulinum toxin.

Acta neurologica Belgica·2012
Same journal

Clinical response after cerebrospinal fluid shunting in complex versus pure idiopathic normal pressure hydrocephalus: A systematic review and meta-analysis.

Clinical neurology and neurosurgery·2026
Same journal

Preoperative sleep medication use and outcomes following lumbar spine surgery.

Clinical neurology and neurosurgery·2026
Same journal

Long-term real-world outcomes and device management of intrathecal drug delivery systems: A 16-year single-center experience with a primary focus on baclofen therapy.

Clinical neurology and neurosurgery·2026
Same journal

Trends and safety of outpatient versus inpatient lumbar interbody fusion - A national cohort study.

Clinical neurology and neurosurgery·2026
Same journal

A case report on αIN antibody-mediated paraneoplastic cerebellar ataxia.

Clinical neurology and neurosurgery·2026
Same journal

Early prediction of prolonged mechanical ventilation in invasively ventilated patients with subarachnoid hemorrhage: A MIMIC-IV prediction model study.

Clinical neurology and neurosurgery·2026
See all related articles

Disseminated encephalomyelitis (DEM) is often misdiagnosed as multiple sclerosis (MS). Characteristic MRI findings and distinct clinical symptoms can help differentiate these conditions, improving patient treatment.

Area of Science:

  • Neurology
  • Neuroimaging
  • Immunology

Background:

  • Multiple Sclerosis (MS) and Disseminated Encephalomyelitis (DEM) are neurological conditions that can present with overlapping symptoms, leading to diagnostic challenges.
  • Magnetic Resonance Imaging (MRI) has become a crucial tool in diagnosing neurological disorders, offering detailed insights into brain and spinal cord abnormalities.

Observation:

  • Acute, recurrent (R-DEM), and multiphasic (M-DEM) forms of DEM are more common in adults than previously thought.
  • MRI scans often display characteristic patterns for DEM, enabling differentiation from MS.
  • Clinical presentations of DEM include symptoms rarely seen in MS, such as fever, malaise, nausea, vomiting, convulsions, and bilateral optic neuritis.

Findings:

  • DEM typically lacks cerebrospinal fluid (CSF) oligoclonal bands, a common marker in MS.

Related Experiment Videos

  • Despite extensive literature and characteristic MRI findings, diagnostic confusion between DEM and MS persists.
  • DEM is frequently misdiagnosed as MS, Schilder's disease, Marburg's disease, Devic's disease, Baló's disease, or brain tumors.

    • Implications:

    • Accurate differentiation between R-DEM, M-DEM, and MS is critical for appropriate patient management.
    • Misdiagnosis can delay or lead to incorrect treatment, particularly with the advent of immunomodulatory therapies for early MS intervention.
    • Understanding the distinct clinical and imaging features of DEM is essential for neurologists to ensure timely and correct diagnosis.